TSB and CR Pharma partner for Covid-19 antibody therapy in China
The companies will expedite the stockpiling, channel distribution and offer access to hospitals for the antibody therapy.

The companies will expedite the stockpiling, channel distribution and offer access to hospitals for the antibody therapy.
In Phase II/III KidCOVE trial, the vaccine offered a strong neutralising antibody response in children.
The authorisation is based on analysis findings from all available data on the vaccine and its usage in children.
In Phase II/III KidCOVE trial, two doses of the vaccine offered strong neutralising antibody response in the young children.
The FDA granted EUA to the Novavax Covid-19 vaccine based on data from the pivotal Phase III PREVENT-19 clinical trial.
NVX-CoV2373 is created from the genetic sequence of the SARS-CoV-2 virus’ initial strain.
The FDA granted approval based on findings from a Phase III clinical trial in 2,260 subjects aged 12 to 15…
The revised EUA has certain limitations to guarantee suitable assessment of the patient and prescribing of the antiviral.
Thank you for subscribing to Pharmaceutical Technology